This guide is for educational purposes only and is not medical advice. None of the peptides below is FDA approved to treat any condition, and compounded medications have not been reviewed by the FDA for safety, effectiveness, or quality. This guide does not provide dosing. Talk with a licensed clinician before starting any new treatment.
Healing peptides are one of the most hyped corners of wellness, and most of what you read online comes from sellers. We ranked five popular options by what human studies actually show for wounds, tendons, and recovery, not by animal results or forum reports.
The short version: two peptides have meaningful human data, and three rely mostly on animal research. Here is how they compare.
Healing Peptides Compared
| Rank | Peptide | Best human evidence | What it was studied for | Regulatory status | Best for |
|---|---|---|---|---|---|
| 1 | GHK-Cu | Placebo controlled ulcer trial | Diabetic foot ulcers (topical) | Compounded by prescription | Wound and skin repair |
| 2 | Collagen peptides | Small randomized trials | Tendon and ligament injuries (oral) | Dietary supplement | Training recovery |
| 3 | TB-500 | Phase 2 trials of the parent protein | Venous and pressure ulcers (topical) | Not FDA approved | Research interest only |
| 4 | BPC-157 | 3 small, low quality studies | Knee pain, bladder pain | Not FDA approved | Research interest only |
| 5 | KPV | None in humans | Gut inflammation in mice | Not FDA approved | Research interest only |
Full Reviews
1. GHK-Cu: Best studied for wounds
GHK-Cu is a copper peptide found naturally in the body. In a multicenter, placebo controlled trial of people with diabetic foot ulcers, a GHK-Cu gel increased median plantar ulcer closure to 98.5% versus 60.8% with vehicle and lowered infection rates. Reviews also describe its effects on collagen and tissue repair across skin, bone, and other tissues, mostly from lab work. The human data come from topical use, which is why most research on GHK-Cu for wound healing and tissue repair focuses on creams and gels. It is also available as a physician prescribed GHK-Cu injectable after a clinician review.
Not for: people with Wilson disease or a copper allergy, or during pregnancy or breastfeeding.
Our score breakdown: Evidence 6, Results 6, Mechanism 8, Safety 8, Access 8.
2. Collagen Peptides: Best oral option
Collagen peptides are hydrolyzed collagen taken as a powder or drink. A 2026 systematic review found that collagen based treatments were linked to improvements in pain, function, and imaging after tendon and ligament injuries, but most studies were small and used multi ingredient formulas. They are safe, cheap, and easy to add to a rehab plan, though they will not replace physical therapy. Some people pair oral collagen with topical copper peptides for post workout recovery and muscle repair, though that combination has not been studied.
Not for: anyone expecting a quick fix for a serious injury.
Our score breakdown: Evidence 6, Results 5, Mechanism 5, Safety 9, Access 10.
3. TB-500: Mixed human results
TB-500 is a synthetic fragment of thymosin beta 4, a protein involved in cell movement and tissue repair. Topical gels of the full thymosin beta 4 protein were tested in phase 2 ulcer trials, where they were safe and well tolerated, but healing differences versus placebo were not statistically significant. The injected TB-500 fragment sold today has not been tested in published human trials, and it is not FDA approved.
Not for: anyone looking for a proven or FDA approved treatment.
Our score breakdown: Evidence 3, Results 3, Mechanism 7, Safety 5, Access 3.
4. BPC-157: Mostly animal evidence
BPC-157 has a large body of animal research. A 2025 systematic review found 35 preclinical studies and just 1 clinical study in orthopedic sports medicine, and noted it is banned in professional sports. A 2026 review of all human evidence found only three small studies and rated the certainty of evidence as very low, recommending against use outside clinical trials. In July 2026, an FDA advisory committee reviewed BPC-157, TB-500, and KPV for possible compounding use, but no final decision has been made.
Not for: anyone treating an injury outside a clinical trial.
Our score breakdown: Evidence 2, Results 2, Mechanism 6, Safety 3, Access 2.
5. KPV: Earliest stage
KPV is a three amino acid fragment of an anti inflammatory hormone. In lab and mouse studies, it reduced intestinal inflammation in two models of colitis. There are no published human trials for wound healing or injury recovery, so any benefit is theoretical for now.
Not for: anyone who wants evidence from human studies.
Our score breakdown: Evidence 1, Results 1, Mechanism 5, Safety 4, Access 3.
Do Peptides Heal Wounds Faster?
The best evidence is for topical GHK-Cu, which improved diabetic ulcer closure in a controlled human trial. Thymosin beta 4 gels looked promising in early trials but did not clearly beat placebo. For everyday cuts and surgical wounds, good wound care, nutrition, and blood sugar control still matter far more than any peptide.
Does BPC-157 Heal Broken Bones?
Not based on human evidence. Faster bone, tendon, and muscle healing with BPC-157 has been shown in animals, but no human trial has tested it for fractures. If you have a broken bone, standard orthopedic care is the proven path.
What Peptides Work Best for Recovery?
For training recovery, collagen peptides have the most human research and the best safety profile. GHK-Cu has the strongest human wound data. Injected peptides such as BPC-157, TB-500, and KPV are widely discussed online, but their human evidence is thin and their legal status is unsettled. Sourcing and medical oversight matter for every injectable peptide, and they sit at the center of the question of whether GHK-Cu is safe.
What the Evidence Does and Does Not Support
The evidence supports topical GHK-Cu for diabetic ulcer healing based on one controlled trial, and collagen peptides as a modest add on to rehab. It does not support claims that BPC-157, TB-500, or KPV heal injuries in people, because nearly all of their data come from animals. None of these peptides is FDA approved for healing, and research grade products bought online carry real quality risks.
References
- Mulder GD, Patt LM, Sanders L, et al. Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-l-histidyl-l-lysine copper. Wound Repair and Regeneration. 1994;2(4):259 to 269. https://pubmed.ncbi.nlm.nih.gov/17147644/
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. 2018;19(7):1987. https://pmc.ncbi.nlm.nih.gov/articles/PMC6073405/
- Latini L, Porta F, Vitale N, Vreju FA, Filippucci E. Clinical evidence for low-molecular-weight collagen peptides in tendon and ligament tears: a systematic review with narrative synthesis. Frontiers in Medicine. 2026;13:1891011. https://pmc.ncbi.nlm.nih.gov/articles/PMC13523136/
- Fierce Biotech. RegeneRx Reports Phase II Venous Stasis Trial Results. March 26, 2009. https://www.fiercebiotech.com/biotech/regenerx-reports-phase-ii-venous-stasis-trial-results
- Vasireddi N, Hahamyan H, Salata MJ, et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS Journal. 2025;21(4):485 to 495. https://pmc.ncbi.nlm.nih.gov/articles/PMC12313605/
- Poolton JT, Minett J, Kazmi A. Human evidence for BPC-157 in orthopaedic and regenerative medicine: a systematic review of efficacy and safety. Acta Orthopaedica Belgica. 2026;92(3). https://pubmed.ncbi.nlm.nih.gov/42885452/
- Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166 to 178. https://pmc.ncbi.nlm.nih.gov/articles/PMC2431115/
- US Food and Drug Administration. July 23 to 24, 2026: Meeting of the Pharmacy Compounding Advisory Committee. https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026